New York State Common Retirement Fund Verona Pharma PLC Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Verona Pharma PLC stock. As of the latest transaction made, New York State Common Retirement Fund holds 6,143 shares of VRNA stock, worth $378,347. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,143Holding current value
$378,347% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding VRNA
# of Institutions
189Shares Held
68.6MCall Options Held
746KPut Options Held
687K-
Perceptive Advisors LLC New York, NY6.32MShares$389 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$344 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$309 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$260 Million2.52% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$208 Million5.24% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.75B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...